Tyra Biosciences, Inc.
TYRA
$31.88
$0.943.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.38% | 11.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.01% | 10.84% | |||
| Operating Income | -15.01% | -10.84% | |||
| Income Before Tax | -16.17% | -13.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.17% | -13.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.17% | -13.28% | |||
| EBIT | -15.01% | -10.84% | |||
| EBITDA | -15.05% | -10.88% | |||
| EPS Basic | -12.57% | -12.99% | |||
| Normalized Basic EPS | -12.56% | -12.98% | |||
| EPS Diluted | -12.57% | -12.99% | |||
| Normalized Diluted EPS | -12.56% | -12.98% | |||
| Average Basic Shares Outstanding | 3.19% | 0.27% | |||
| Average Diluted Shares Outstanding | 3.19% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||